相关实验视频

Updated: Jul 3, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

最小残留疾病检测:对临床诊断和癌症患者治疗的影响

Meiling Song¹, Wenjing Pan^2,3,4, Xinjie Yu¹

¹Hunan Key Laboratory of Biomedical Nanomaterials and Devices Hunan University of Technology Zhuzhou China.

|May 19, 2025

概括

精确的最小残留疾病 (MRD) 检测对于血液癌症患者至关重要. 本综述分析了当前和新兴的MRD检测方法,以改善患者的治疗结果和个性化治疗策略.

科学领域:

在瘤学瘤学.
生物标志物生物标志物
癌症的诊断癌症的诊断

背景情况:

最小残留疾病 (MRD) 是癌症诊断和治疗中的关键生物标志物.
血液性恶性瘤对健康构成重大威胁,需要精确检测MRD,以评估复发风险和优化治疗.
目前的MRD检测方法,如流细胞计,PCR和NGS在灵敏度和特异性方面存在局限性.

研究的目的:

对血液性恶性瘤的MRD检测方法进行全面审查.
突出MRD检测对治疗决策,风险分层和患者结果的临床影响.
探索新兴技术和进步,以提高诊断精度.

主要方法:

分析现有的MRD检测技术 (流细胞计,PCR,NGS).
评估新兴技术,包括液体活检和集成NGS方法.
对MRD检测的临床影响和未来方向的审查.

主要成果:

现有的MRD检测方法具有固有的局限性,影响敏感性和特异性.
新兴技术和综合方法显示出改善诊断准确性的前景.
准确和早期检测MRD显著影响患者管理和治疗结果.

结论:

加强MRD检测对于改善患者管理和血液恶性瘤的结果至关重要.
解决目前的技术差距和探索新方法将推动个性化癌症医学.
这一审查为未来的研究和先进的MRD检测策略的临床应用提供了基础.

关键词:

在MRD中,我们可以使用MRD.临床影响临床影响检测方法检测方法这是下一代测序.

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...